Immune histological proof (brown) of Vascular Endothelial Growth Factors (VEGF) in breast cancer. VEGF plays a key role in the tumorneoangiogenesis. With the aid of the newly developed antibody Bevacizumab (Avastin®), VEGF can be blocked.